The Translational Research Program supports research projects focused on decreasing the time between laboratory findings and actual treatment. With a maximum of $200,000, the grant is attributed to new and innovative projects that demonstrate high promise for translating basic biomedical knowledge to clinical application, and it aims to fast-track the development of more effective treatments and a cure for leukemia, lymphoma, and myeloma. The application process for the Translational Research Program is currently closed since applications are under review.